Abstract

The binding of human high-density lipoprotein (HDL 3), apolipoprotein A-I (apoA-I) and recombinants of apoA-I with cholesterol and/or dimyristoylphosphatidylcholine (DMPC) to the HDL receptor on isolated human small intestine epithelial cells was studied. ApoA-I competed for 125I-labelled HDL 3 binding sites less effectively than HDL 3, and a lower amount of 125I-labelled apoA-I than 125I-HDL 3 was bound to cells. The apoA-I/DMPC recombinant competed for 125I-HDL 3 binding sites nearly as well as HDL 3, and 125I-apoA-I/DMPC recombinant bound to cells with at least the same efficiency as 125I-HDL 3. The apoA-I/DMPC/ cholesterol recombinant failed to compete for 125I-HDL 3 binding sites, and the 125I-apoA-I/DMPC/ cholesterol complex binding to cells was several-fold lower than that of other particles. All particles bound to cells with similar dissociation constants. Tetranitromethane-modified HDL 3 failed to bind to high-affinity specific binding sites and compete with 125I-HDL 3 for binding. The results obtained make it possible to assume that, while apoA-I may be a determinant of the HDL receptor, the lipid composition of the lipoprotein may affect its interaction with the receptor.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.